Immune function and therapeutic effectiveness of children with immune thrombocxtopenic purpura and Helicobacter pylori infection
10.3969/j.issn.1671-9638.2014.06.008
- VernacularTitle:免疫性血小板减少性紫癜合并幽门螺杆菌感染患儿免疫功能变化及治疗效果
- Author:
Yi WU
- Publication Type:Journal Article
- Keywords:
Kex words] immune thrombocytopenic purpura;
Helicobacter pylori;
child;
immune function
- From:
Chinese Journal of Infection Control
2014;(6):353-355
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the change in immune function and therapeutic effectiveness of children with im-mune thrombocytopenic purpura and Helicobacter pylori(H. pylori)infection. Methods Eighty hospitalized chil-dren with thrombocytopenic purpura between March 2011 and March 2012 were as observation group,and then sub-divided into infected group and non-infected group according to whether they were infected with H. pylori;80 healthy children were as control group . Lymphocyte subsets ,clinical therapeutic effectiveness and recurrence rate among three groups were compared. Results The positive rate of H. pylori in observation group was significantly higher than control group(55.00% [44/80]vs 2.50% [2/80];χ2= 12.48,P= 0.008). There was significant differences in CD4+,CD4+/CD8+ ,and CD19+T lymphocyte among three groups (all P<0.05);CD4+ and CD4+/CD8+ T lymphocyte in infected group was significantly lower than non-infected group respectively ([13.40±4.65]% )vs [28.56± 3.82]% ;[0.69±0.18]% vs [1.04±0.23]% ),and CD19+T lymphocyte in infected group was significantly higher than non-infected group ([45.21±10.20]% vs [22.05±2.23]% );CD4+ and CD4+/CD8+T lymphocyte in non-in-fected group and infected group was significantly lower than control group ([40.20±3.42]% ,[1.54±0.42]% respec-tively),and CD19+T lymphocyte was significantly higher than control group ([11.02±2.89]% ). The overall therapeu-tic effectiveness in infected group and non-infected group was 90.91% and 91.67% respectively(P>0.05). The recur-rence rate of thrombocytopenic purpura after anti-H.pylori infection therapy in infected group was significantly lower than non-infected group (20.45% vs 30.56% ;χ2= 6.396,P= 0.038). Conclusion Detection of immune function is helpful for clinical diagnosis of H. pylori infection associated with immune thrombocytopenic purpura .